Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesChromosomal abnormalities, not elsewhere classifiedICD-10-CM q93-monosomies-and-deletions
    Ask Trek AI about this page

    ICD-10-CM Code For Monosomies And Deletions From The Autosomes Not Elsewhere Classified: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group Q93 includes congenital monosomies and deletions of autosomal chromosomes not classified elsewhere, covering partial or complete loss of chromosomal material with variable phenotypic consequences. These ICD-10-CM diagnosis codes are used to document congenital chromosomal abnormalities that may present with developmental delay, structural malformations, or multisystem involvement and to capture the extent and specificity of genetic findings. Accurate coding within the ICD-10-CM Q93 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Monosomies And Deletions From The Autosomes Not Elsewhere Classified: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM Q93: Monosomies And Deletions From The Autosomes, Not Elsewhere Classified Overview

    This group includes congenital chromosomal deletion and monosomy disorders affecting autosomes, often identified prenatally or at birth due to developmental anomalies. These conditions target genetic and developmental systems with variable multisystem involvement depending on the specific chromosomal deletion. Accurate coding matters for reimbursement because it links documented genetic findings to appropriate diagnostic and care pathways.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Select a code from this group when a confirmed chromosomal monosomy or deletion of an autosome has been identified by cytogenetic or molecular testing and documented in the medical record. Use the most specific code available to reflect the affected chromosome and extent of deletion for accurate clinical documentation and billing.

    ICD-10-CM Codes

    14 rows

    ICD-10-CM CodeDescription
    Q93.0Whole chromosome monosomy, nonmosaicism (meiotic nondisjunction)
    Q93.1Whole chromosome monosomy, mosaicism (mitotic nondisjunction)
    Q93.2Chromosome replaced with ring, dicentric or isochromosome
    Q93.3Deletion of short arm of chromosome 4
    Q93.4Deletion of short arm of chromosome 5
    Q93.51Angelman syndrome
    Q93.52Phelan-McDermid syndrome
    Q93.59Other deletions of part of a chromosome
    Q93.7Deletions with other complex rearrangements
    Q93.81Velo-cardio-facial syndrome
    Q93.82Williams syndrome
    Q93.88Other microdeletions
    Q93.89Other deletions from the autosomes
    Q93.9Deletion from autosomes, unspecified

    DRG Codes

    2 rows

    DRG CodeDescription
    884Organic Disturbances and Intellectual Disability
    951Other Factors Influencing Health Status

    Typical Clinical Scenarios

    • A newborn is delivered with multiple congenital anomalies discovered on initial physical exam and neonatal assessment, including dysmorphic facial features, limb malformations, and growth restriction. Genetic testing (microarray or karyotyping) confirms a partial monosomy of chromosome 5p consistent with a deletion syndrome, and the infant is referred to neonatology and genetics for further evaluation and supportive management. Typical codes: Q93.2.
    • An adult patient with a history of lifelong intellectual disability and short stature presents to primary care for routine management of chronic health issues and coordination of specialty care. Prior chromosomal analysis documents a constitutional deletion involving chromosome 4q leading to established developmental delays and congenital anomalies; the clinician documents this chromosomal abnormality as a comorbidity affecting care planning. Typical codes: Q93.1.
    • A pregnant woman undergoes prenatal ultrasound showing fetal structural anomalies; follow-up chorionic villus sampling identifies a fetal partial deletion of an autosome not involving sex chromosomes. The pregnancy is managed with maternal–fetal medicine consultation to assess prognosis and counsel on options, and the fetal chromosomal deletion is coded for prenatal diagnosis and counseling encounters. Typical codes: Q93.3, Q93.4.

    Related Codes

    Q90-DOWN-SYNDROME

    ICD-10-CM Code For Down Syndrome: Group Overview

    Q91-TRISOMY-18-AND-TRISOMY-13

    ICD-10-CM Code For Trisomy 18 And Trisomy 13: Group Overview

    Q92-OTHER-TRISOMIES-AND-PARTIAL-TRISOMIES

    ICD-10-CM Code For Other Trisomies And Partial Trisomies Of The Autosomes Not Elsewhere Classified: Group Overview

    Q95-BALANCED-REARRANGEMENTS-AND-STRUCTURAL-MARKERS

    ICD-10-CM Code For Balanced Rearrangements And Structural Markers Not Elsewhere Classified: Group Overview

    Q96-TURNERS-SYNDROME

    ICD-10-CM Code For Turner's Syndrome: Group Overview

    Q97-OTHER-SEX-CHROMOSOME-ABNORMALITIES-FEMALE-PHENOTYPE

    ICD-10-CM Code For Other Sex Chromosome Abnormalities Female Phenotype Not Elsewhere Classified: Group Overview

    Q98-OTHER-SEX-CHROMOSOME-ABNORMALITIES-MALE-PHENOTYPE

    ICD-10-CM Code For Other Sex Chromosome Abnormalities Male Phenotype Not Elsewhere Classified: Group Overview

    Q99-OTHER-CHROMOSOME-ABNORMALITIES-NOT-ELSEWHERE-CLASSIFIED

    ICD-10-CM Code For Other Chromosome Abnormalities, Not Elsewhere Classified: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.